4559.T
ZERIA PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 1,992.00
−0.94%Year over year
Reported trailing growth
- Revenue
- +4.9%
- EBITDA
- —
- EBIT
- +1.3%
- EPS
- -3.6%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +3.9%
- EBITDA
- —
- EPS
- +30.8%
Three-year CAGR
- Revenue
- +13.6%
- EBITDA
- +19.8%
- EBIT
- +24.2%
- Net income
- +35.9%
- EPS
- +37.0%
- Free cash flow
- +13.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026